Search Results - "Agahigian, Jennifer"

  • Showing 1 - 2 results of 2
Refine Results
  1. 1
    Multicenter Study of a Novel Topical Interleukin-1 Receptor Inhibitor, Isunakinra, in Subjects With Moderate to Severe Dry Eye Disease

    Multicenter Study of a Novel Topical Interleukin-1 Receptor Inhibitor, Isunakinra, in Subjects With Moderate to Severe Dry Eye Disease by Goldstein, Michael H, Martel, Joseph R, Sall, Kenneth, Goldberg, Damien F, Abrams, Marc, Rubin, Jay, Sheppard, John, Tauber, Joseph, Korenfeld, Michael, Agahigian, Jennifer, Durham, Todd A, Furfine, Eric

    Published in Eye & contact lens (01-09-2017)
    “…OBJECTIVES:Isunakinra, formerly known as EBI-005, is a novel interleukin (IL)-1 receptor inhibitor developed for topical treatment of patients with dry eye…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  2. 2
    A Phase 2 Exploratory Study of a Novel Interleukin-1 Receptor Inhibitor (EBI-005) in the Treatment of Moderate-to-Severe Allergic Conjunctivitis

    A Phase 2 Exploratory Study of a Novel Interleukin-1 Receptor Inhibitor (EBI-005) in the Treatment of Moderate-to-Severe Allergic Conjunctivitis by Goldstein, Michael H, Tubridy, Karen L, Agahigian, Jennifer, Furfine, Eric, Magill, Marianne, Kovalchin, Joseph, Golden, Kathryn, Zarbis-Papastoitsis, Gregory, Soong, Fiona, Salapatek, Anne Marie, Sternberg, Gary, Celniker, Abbie

    Published in Eye & contact lens (01-05-2015)
    “…OBJECTIVES:Many allergic conjunctivitis (AC) patients are inadequately treated with conventional therapies or require steroids. EBI-005 was developed to…”
    Get full text
    Journal Article
    Save to List
    Saved in:

Search Tools: